Home » Topics » Disease categories and therapies » Ear, nose and throat

Ear, nose and throat
RSS

Peptide P-13 ameliorates experimental otitis media

July 14, 2011

Sanofi and Audion Therapeutics to develop treatments for hearing loss

June 17, 2011

Sound Pharmaceuticals begins trial of SPI-1005 for hearing loss induced by loud music

June 8, 2011

Otonomy reports encouraging phase Ib data on OTO-104 in Meniere's disease

May 2, 2011

Auris Medical advances phase IIb trial of AM-111 for acute sensorineural hearing loss

Jan. 24, 2011

Neramexane mesilate is safe and well tolerated in subjects with tinnitus

Jan. 18, 2011

Auris Medical advances phase IIb trial of AM-111 in acute sensorineural hearing loss

Nov. 26, 2010

GenVec achieves milestone in collaboration with Novartis

Sep. 15, 2010

Otonomy closes Series B financing

Sep. 1, 2010

Topical nitroglycerin improves symptoms of chondrodermatitis nodularis helicis

Aug. 16, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...